NO20006243L - Beskyttelse av neuroner fra ischemi - Google Patents

Beskyttelse av neuroner fra ischemi

Info

Publication number
NO20006243L
NO20006243L NO20006243A NO20006243A NO20006243L NO 20006243 L NO20006243 L NO 20006243L NO 20006243 A NO20006243 A NO 20006243A NO 20006243 A NO20006243 A NO 20006243A NO 20006243 L NO20006243 L NO 20006243L
Authority
NO
Norway
Prior art keywords
neurons
ischemia
protection
bilobalide
stimulation
Prior art date
Application number
NO20006243A
Other languages
English (en)
Other versions
NO20006243D0 (no
Inventor
Krish Chandrasekaran
Katy Drieu
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of NO20006243D0 publication Critical patent/NO20006243D0/no
Publication of NO20006243L publication Critical patent/NO20006243L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Anvendelsen av et ekstrakt av ginkgo biloba omfattende bilobalid for å beskytte neuroner mot iskemisk skade assosiert med stimulering av mitokondriell genekspresjon, beskrives.
NO20006243A 1998-06-11 2000-12-08 Beskyttelse av neuroner fra ischemi NO20006243L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9686998A 1998-06-11 1998-06-11
US8912698P 1998-06-11 1998-06-11
PCT/EP1999/004098 WO1999064028A1 (en) 1998-06-11 1999-06-10 Protecting neurons from ischemia

Publications (2)

Publication Number Publication Date
NO20006243D0 NO20006243D0 (no) 2000-12-08
NO20006243L true NO20006243L (no) 2001-02-08

Family

ID=26780277

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006243A NO20006243L (no) 1998-06-11 2000-12-08 Beskyttelse av neuroner fra ischemi

Country Status (8)

Country Link
EP (1) EP1085886A1 (no)
JP (1) JP2002517456A (no)
KR (1) KR20010078734A (no)
AU (1) AU4772099A (no)
CA (1) CA2331918A1 (no)
IL (1) IL140196A0 (no)
NO (1) NO20006243L (no)
WO (1) WO1999064028A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7226916B1 (en) 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
US7585523B2 (en) * 2002-08-27 2009-09-08 Targeted Medical Pharma Composition and method to augment and sustain neurotransmitter production
KR100623164B1 (ko) * 2004-07-22 2006-09-19 재단법인서울대학교산학협력재단 뇌신경 보호효과를 갖는 신규한 은행잎 엑스를 정제하는방법 및 이를 함유하는 조성물
KR100723609B1 (ko) * 2006-04-28 2007-06-04 주식회사 유유 신규한 조성의 알츠하이머형 치매 및 파킨슨씨병 예방 또는 치료용 은행잎 추출물, 그리고 은행잎으로부터의 추출 및 정제 방법
FR2904222A1 (fr) 2006-07-27 2008-02-01 Sod Conseils Rech Applic Utilisation d4extraits de ginkgo biloba pour le traitement de maladies mitochondriales
MX2009001966A (es) * 2006-08-23 2009-06-19 Univ Montana Metodo de reduccion del daño celular neuronal.
WO2012047063A2 (ko) * 2010-10-08 2012-04-12 제일약품주식회사 당귀 추출물, 은행엽 추출물 단독； 또는 당귀 추출물 및 은행엽 추출물의 혼합물을 포함하는 치매 치료보조용 또는 치매치료용 약학적 조성물
CN105125897A (zh) * 2015-10-05 2015-12-09 南京多宝生物科技有限公司 一种含天麻的植物组合物提取方法和应用
CN110893183A (zh) * 2018-09-13 2020-03-20 成都百裕制药股份有限公司 银杏萜内酯在制备预防、缓解或治疗肌萎缩侧索硬化药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3338995A1 (de) * 1983-10-27 1985-05-09 Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe Bilobalid enthaltende arzneimittel
DE3940094A1 (de) * 1989-12-04 1991-06-06 Montana Ltd Wirkstoffkonzentrate und neue wirkstoff-kombinationen aus blaettern von ginkgo biloba, ein verfahren zu ihrer herstellung und die wirkstoff-konzentrate bzw. die wirkstoff-kombinationen enthaltenden arzneimittel
IT1238684B (it) * 1990-02-09 1993-09-01 Indena Spa Derivati del bilobalide,loro usi e formulazioni che li contegono

Also Published As

Publication number Publication date
NO20006243D0 (no) 2000-12-08
IL140196A0 (en) 2002-02-10
AU4772099A (en) 1999-12-30
EP1085886A1 (en) 2001-03-28
KR20010078734A (ko) 2001-08-21
JP2002517456A (ja) 2002-06-18
WO1999064028A1 (en) 1999-12-16
CA2331918A1 (en) 1999-12-16

Similar Documents

Publication Publication Date Title
IT7829949A0 (it) Dispositivo per serratura per evitare l'accesso non autorizzato.
DE60022756D1 (de) Hautpflegezusammensetzung
WO2002022611A3 (en) Caspase inhibitors and uses thereof
FI883953A0 (fi) Anordning foer anvaendning vid hantering av organiska kroppsvaetskor.
NO962059L (no) Antiarytmiske benzodiazepiner
ES2164088T3 (es) Antagonistas de la sustancia p para el tratamiento de la emesis.
DE50104383D1 (de) Benzofuranonderivate enthaltende formulierung zum schutz vor oxidativem stress
NO20006243L (no) Beskyttelse av neuroner fra ischemi
FI884965L (fi) Vid uppspjaelkning av oximer haerdande i k rtv-massor.
DK0693278T3 (da) Kombinationer af vasoaktive stoffer med fedtsyrer for at forebygge tab af hår
ES2060918T3 (es) Derivados de ciclopropilo que poseen actividad inhibidora lipoxigenasa.
DE3875866D1 (de) Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie.
IE43618L (en) Benzimidazole derivatives
DK76788A (da) Tyveribeskyttelse
BE883068A (fr) Derives de benzimidazole, leur preparation, et utilisation ainsi que compositions contenant ces derives
FI885243A0 (fi) Foerfarande foer framstaellning av stabiliserade olefinpolymerer.
DE3687283D1 (de) Mittel zum schutz des gehirns.
ATE108993T1 (de) Lichtschutz.
IT8619382A0 (it) Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.
TR200400397T4 (tr) Güvenlik tekniği açısından iyileştirilmiş pigment preparatları
AT3862U3 (de) Zerkleinerungsvorrichtung nach dem prinzip der rotorzerkleinerung
IT8619201A0 (it) Triazol derivati e loro impiego per stabilizzare polimeri organici.
ATE118007T1 (de) Penemderivate.
KR890700028A (ko) 약제학적 활성화합물 및 이의 혼합물, 유기조성물 및 금속염
SU628921A1 (ru) Вещество, обладающее антикурарным действием дл использовани в экспиременте

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application